FeesSafety
Pluang+

Wix rated Buy as AI tools like Base44 drive strong growth and promise 95% upside by 2028

Analyst Insights
11 Oct 2026, 14:59 WIB
Seeking Alpha
View Source
Bullish
Wix rated Buy as AI tools like Base44 drive strong growth and promise 95% upside by 2028

Wix is rated a Buy despite concerns about AI disruption because it is successfully adapting and expanding with AI-driven products like Base44 and Wix Studio. Base44, an AI-powered vibe-coding tool, achieved $100 million annual recurring revenue within a year and is projected to reach 60% gross margins by mid-2026. Wix's strategy leverages customer loyalty and broadening services to maintain steady revenue growth and strong cash flow. The stock valuation suggests nearly 95% upside by 2028, based on a conservative 12x EV/FCF multiple and a $146 price target, indicating a significant margin of safety for investors.

Wix's market context is provided as of Oct 11, 2026 18:31 WIB. For readers following the Technology sector, here is Pluang's market snapshot: out of 150 priced US Technology stocks tradable on Pluang, 104 rose and 46 fell today. Notable movers include SNOW at USD 368.89 with a 7.42% increase, DDOG at USD 293.26 with a 7.11% increase and strong buy order activity of 87%, and VNET at USD 5.53 with a 6.96% increase. The most notable figure is SNOW's 7.42% price rise.

More News

Anteris reports positive 30-day results for Medium-size DurAVR heart valve in severe aortic stenosis patients

Anteris reports positive 30-day results for Medium-size DurAVR heart valve in severe aortic stenosis patients

Anteris Technologies announced favorable 30-day clinical outcomes for its Medium-size DurAVR Transcatheter Heart Valve (THV) in 22 patients with severe aortic stenosis. The valve showed excellent hemodynamics with low pressure gradients, large effect...

Market News
Bullish
3 hours ago
CT-guided PCI matches IVUS outcomes with faster procedures and less contrast, changing treatment plans in 70% of cases.

CT-guided PCI matches IVUS outcomes with faster procedures and less contrast, changing treatment plans in 70% of cases.

A landmark P4 randomized trial showed that CT-guided percutaneous coronary intervention (PCI) delivers clinical outcomes comparable to the gold-standard intravascular ultrasound (IVUS) at one year, while reducing procedure time by 27% and contrast us...

Market News
Bullish
4 hours ago
Bitcoin miners earned $1.215B in October, but daily revenue per unit dropped 17.5% in November.

Bitcoin miners earned $1.215B in October, but daily revenue per unit dropped 17.5% in November.

Bitcoin miners collectively earned $1.215 billion in October, marking the strongest month since November 2025, though still below November 2025's $1.26 billion. Despite this high monthly revenue, the daily revenue per unit of mining power (hashprice)...

Protocol Fundamentals
Neutral
5 hours ago
Bitcoin miners hit 11-month revenue high in October despite 17.5% drop in mining profitability.

Bitcoin miners hit 11-month revenue high in October despite 17.5% drop in mining profitability.

In October 2026, Bitcoin miners earned their highest monthly revenue since November 2025, totaling $1.215 billion, despite a 7.3% drop in Bitcoin's price and a 17.54% decline in mining profitability (hashprice). This paradox occurred because the Bitc...

Protocol Fundamentals
Neutral
5 hours ago
Amazon shares dip after earnings miss, but Jim Cramer advises buying on strong AWS growth and record margins.

Amazon shares dip after earnings miss, but Jim Cramer advises buying on strong AWS growth and record margins.

Amazon's stock fell after its Q3 earnings showed revenue and EPS slightly below estimates, and guidance for Q4 sales was also cautious. However, Jim Cramer recommends buying the stock, highlighting strong growth in Amazon Web Services (AWS), which po...

Company Fundamentals
Neutral
6 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App